STAT
MAY 3, 2024
A new report on the first human bird flu case tied to the outbreak in cows in the United States suggests that the Texas man may be the first detected case of the H5N1 virus transmitting from a mammal to a person. Nearly 900 people in 23 countries have been infected with the H5N1 bird flu virus since it started spreading from Southeast Asia in late 2003.
PharmaVoice
MAY 3, 2024
With its next earnings report looming, pushback from an investor is adding pressure on Novavax to boost performance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 3, 2024
Vivien Dugan isn’t getting much sleep these days. The director of the influenza division at the Centers for Disease Control and Prevention, Dugan is leading the team of CDC scientists that is working with partners — in the U.S. Department of Agriculture, the Food and Drug Administration, and state and local health departments — to respond to the H5N1 bird flu outbreak in dairy cattle.
BioPharma Dive
MAY 3, 2024
Newly disclosed Phase 3 results presented Friday match findings the biotech disclosed last year, while offering a more comprehensive look at how its drug stacks up to rival therapies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 3, 2024
Caregivers for older adults and people with disabilities could see a bump in their wages in the coming years, thanks to a forthcoming rule by the Centers for Medicare and Medicaid Services. The new rule brings sweeping changes to a bevy of Medicaid programs throughout the country, including fee-for-service and managed care delivery systems. One of the most notable changes applies to the home and community-based services (HCBS) industry.
pharmaphorum
MAY 3, 2024
Walgreens’ plans to disrupt the clinical trials sector have taken a step forward with a high-profile partnership with Boehringer Ingelheim
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
MAY 3, 2024
Together with our sister publications, The Pharmacist has launched a survey to hear what pharmacists think about the last five years of change in primary care. The State of Primary Care Survey asks how the changes to the NHS — the launch of primary care networks (PCNs) in 2019 and the shift to integrated care systems (ICSs) in 2022 […] The post Have your say on PCN pharmacy and you could win a £200 voucher appeared first on The Pharmacist.
STAT
MAY 3, 2024
Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data for its obesity drug have quickly sparked immense investor interest in what could be a potential contender with Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The injectable drug MariTide, designed to be given monthly, could be a more attractive option than Wegovy and Zepbound, which are both dosed weekly.
BioPharma Dive
MAY 3, 2024
The company said data for its Wegovy competitor was promising enough to move the drug into late-stage testing, triggering a stock jump that added billions to Amgen’s market value.
STAT
MAY 3, 2024
WASHINGTON — Around the country, s tatehouses from Harrisburg, Penn. to Tallahassee, Fla., are being flooded with tobacco industry lobbyists, according to a new report from the anti-smoking advocacy group Action on Smoking and Health. There are now at least 950 lobbyists representing cigarette, vape, and snus companies in statehouses around the country, according to the latest edition of the group’s Tobacco Industry Lobbyist and Lobbying Firm Registration Tracker, which was r
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
MAY 3, 2024
Apple gets FDA okay to use the atrial fibrillation history tool incorporated in some of its Apple Watch devices in clinical trials
STAT
MAY 3, 2024
Telehealth needs a major refresh. Just this week, retail juggernaut Walmart announced it is shuttering its virtual care business. Not long before that, Optum announced the closing of Optum Virtual Care , Teladoc Health announced a change in leadership following a further drop in stock price , and the Peterson Health Technology Institute published a report critical of outcomes generated by most digital diabetes management providers.
Pharmaceutical Business Review
MAY 3, 2024
The financing round is co-led by 8VC and DCVC Bio, with contributions from Samsung Life Science Fund, The Children’s Hospital of Philadelphia Foundation, Benjamin Franklin Technology Partners, Modi Ventures, and Gaingels. Latus Bio, emerging from the lab of co-founder professor Beverly Davidson at the Children’s Hospital of Philadelphia, is utilising proprietary technologies to develop CNS gene therapy candidates.
STAT
MAY 3, 2024
Doctors have observed and treated bipolar disorder for thousands of years. Known throughout history by many names, like depression, mania, manic-depressive illness, or psychosis, the disorder is common and closely tied to that which makes us human: our thinking, our behavior, our hopes, and our ambitions. A solid foundation of science grounds the understanding of bipolar disorder; what’s lacking are strong data about the experience of people with the condition.
Pharmaceutical Technology
MAY 3, 2024
UK liquid biopsy company, Angle, has agreed a supplier agreement with AstraZeneca to develop a Parsotix-based Androgen Receptor (AR) assay for use in prostate cancer studies.
STAT
MAY 3, 2024
WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs. Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists.
Express Pharma
MAY 3, 2024
Lupin announced the launch of Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada. Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile idiopathic arthritis, active and progressive psoriatic arthritis, severe axial spondyloarthritis, moderate to severe plaque psoriasis and chronic severe plaque psoriasis in children and adolescents.
STAT
MAY 3, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch some outdoor sounds, promenade with the official mascots, manicure the grounds, and hold another listening party, where the rotation will likely include this , this , this , this and this.
Express Pharma
MAY 3, 2024
Emcure Pharmaceuticals, unveiled its new corporate campaign with the tagline – ‘Cure and Beyond’, featuring cricketer MS Dhoni. The campaign seeks to raise awareness about Emcure’s operations and cultivate thought leadership within the Indian Pharma Market. It aims to support, and educate people to lead healthier lives. The ad film featuring MS Dhoni, the Ex-captain of the Indian Cricket team, is being launched across various media platforms, encompassing digital, television, and print.
STAT
MAY 3, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! A crowdsourced Readout today, to be sure, with contributions from STAT’s Jason Mast, Elaine Chen, and Jonathan Wosen. We get into earnings from Novo Nordisk, Amgen, and Illumina, and see that ICER is not so enthused about a gene therapy from Sarepta.
Express Pharma
MAY 3, 2024
Naprod Life Sciences announced the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar. The audit was conducted in December 2023 by The National Institute of Pharmacy and Nutrition (OGYÉI), Hungary. Speaking on the development, Mohan Jain, MD, Naprod said, “The EU GMP certification for our facility in Palghar is the result of our consistent compliance with the highest quality standards.
STAT
MAY 3, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
pharmaphorum
MAY 3, 2024
Some NHS patients in the UK will finally be able to access Pfizer’s sickle cell disease therapy Oxbryta after agreement was reached on a price cut
Pharma Times
MAY 3, 2024
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
The Pharmacist
MAY 3, 2024
Use of antipsychotic medications in patients with dementia is linked with a much wider range of serious harms than previously thought, UK researchers have said. Although there have been safety warnings on use of the antipsychotics from regulators about increased risk of stroke and death, a large study has now found increased risks for pneumonia, […] The post Antipsychotics associated with much wider harms in dementia patients than thought appeared first on The Pharmacist.
Pharma Times
MAY 3, 2024
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide
The Pharmacist
MAY 3, 2024
A decline in the number of GP practices in Wales has prompted the Royal Pharmaceutical Society (RPS) to call for government investment, amid concern over the ability of pharmacists working in general practice to deliver high-quality care. Official figures show there were 374 active GP practices in Wales at the end of 2023, which represents […] The post Pharmacy concerns after data reveals drop in Welsh GP practices appeared first on The Pharmacist.
Express Pharma
MAY 3, 2024
DP World, a provider of end-to-end supply chain solutions, has commenced warehousing operations in Loutulim, Goa. Located 31 km from the Mormugaon Port, 23 km from the Dabolim airport and, 25 km from Panjim city, the warehouse is compliant with all safety standards and provides connectivity to the Goa-Bangalore-Pune highway. The facility is fully compliant for the storage and handling of chemicals and healthcare cargo.
Pharmaceutical Technology
MAY 3, 2024
The FDA has awarded the designation following a review of initial safety and efficacy data from two Phase I/II clinical trials.
European Pharmaceutical Review
MAY 3, 2024
In final draft guidance , the National Institute For Health and Care Excellence (NICE) has recommended voxelotor (Oxbryta) with or without hydroxycarbamide as a treatment for haemolytic anaemia, which is caused by sickle cell disease. According to NICE, around 4,000 people aged 12 years and older with sickle cell disease in England will be able to benefit from the treatment.
Pharmaceutical Technology
MAY 3, 2024
Moderna reported a net loss of $1.2bn in the first quarter (Q1) of 2024, a stark contrast to its net income of $79m in Q1 2023.
European Pharmaceutical Review
MAY 3, 2024
An interim analysis of a Phase III trial of Calquence (acalabrutinib) plus chemoimmunotherapy has revealed positive progression-free survival outcomes for adults with untreated mantle cell lymphoma. AstraZeneca ’s ECHO Phase III trial evaluated acalabrutinib in combination with standard-of-care chemoimmunotherapy , bendamustine and rituximab. Calquence (acalabrutinib) is a next-generation, Bruton’s tyrosine kinase (BTK) inhibitor.
Pharmaceutical Technology
MAY 3, 2024
The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle cell disease.
The Guardian - Pharmaceutical Industry
MAY 3, 2024
Inadvertent poisoning of scavengers across Indian subcontinent is forcing some communities to give up ancient custom Traditional Zoroastrian burial rites are becoming increasingly impossible to perform because of the precipitous decline of vultures in India, Iran and Pakistan. For millennia, Parsi communities have traditionally disposed of their dead in structures called dakhma, or “towers of silence”.
World Pharma News
MAY 3, 2024
Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk neuroblastoma, currently more than 40% of patients do not survive. New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA modifications associated with the disease.
Expert insights. Personalized for you.
363 
Let's personalize your content